Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
Gansevoort RT, Hariri A, Minini P, Ahn C, Chapman AB, Horie S, Knebelmann B, Mrug M, Ong ACM, Pei YPC, Torres VE, Modur V, Antonshchuk I, Perrone RD. Gansevoort RT, et al. Am J Kidney Dis. 2023 May;81(5):517-527.e1. doi: 10.1053/j.ajkd.2022.10.016. Epub 2022 Dec 17. Am J Kidney Dis. 2023. PMID: 36535535 Free article. Clinical Trial.
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.
Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium. Gansevoort RT, et al. Kidney Int. 2011 Jul;80(1):93-104. doi: 10.1038/ki.2010.531. Epub 2011 Feb 2. Kidney Int. 2011. PMID: 21289597 Free PMC article.
Prognostic Value of Cardiovascular Biomarkers in the Population.
Neumann JT, Twerenbold R, Weimann J, Ballantyne CM, Benjamin EJ, Costanzo S, de Lemos JA, deFilippi CR, Di Castelnuovo A, Donfrancesco C, Dörr M, Eggers KM, Engström G, Felix SB, Ferrario MM, Gansevoort RT, Giampaoli S, Giedraitis V, Hedberg P, Iacoviello L, Jørgensen T, Kee F, Koenig W, Kuulasmaa K, Lewis JR, Lorenz T, Lyngbakken MN, Magnussen C, Melander O, Nauck M, Niiranen TJ, Nilsson PM, Olsen MH, Omland T, Oskarsson V, Palmieri L, Peters A, Prince RL, Qaderi V, Vasan RS, Salomaa V, Sans S, Smith JG, Söderberg S, Thorand B, Tonkin AM, Tunstall-Pedoe H, Veronesi G, Watanabe T, Watanabe M, Zeiher AM, Zeller T, Blankenberg S, Ojeda F. Neumann JT, et al. Among authors: gansevoort rt. JAMA. 2024 May 13:e245596. doi: 10.1001/jama.2024.5596. Online ahead of print. JAMA. 2024. PMID: 38739396
A Prospective Study of the Association Between Plasma Calprotectin Levels and New-Onset CKD in the General Population.
Bourgonje AR, Bourgonje MF, la Bastide-van Gemert S, Nilsen T, Hidden C, Gansevoort RT, Mulder DJ, Hillebrands JL, Bakker SJL, Dullaart RPF, van Goor H, Abdulle AE. Bourgonje AR, et al. Among authors: gansevoort rt. Kidney Int Rep. 2024 Feb 16;9(5):1265-1275. doi: 10.1016/j.ekir.2024.02.1392. eCollection 2024 May. Kidney Int Rep. 2024. PMID: 38707832 Free PMC article.
Plasma calprotectin and new-onset type 2 diabetes in the general population: a prospective cohort study.
Bourgonje AR, Bourgonje MF, Sokooti S, la Bastide-van Gemert S, Nilsen T, Hidden C, Gansevoort RT, Mulder DJ, Hillebrands JL, Bakker SJL, van Beek A, Dullaart RPF, van Goor H, Abdulle AE. Bourgonje AR, et al. Among authors: gansevoort rt. J Clin Endocrinol Metab. 2024 Mar 4:dgae130. doi: 10.1210/clinem/dgae130. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38436468
Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study.
Bouwmans P, Malahe SRK, Messchendorp AL, Vart P, Imhof C, Sanders JF, Gansevoort RT, de Vries APJ, Abrahams AC, Bemelman FJ, Vervoort JPM, Hilbrands LB, Ten Dam MAGJ, van den Dorpel RMA, Rispens T, Steenhuis M, Reinders MEJ, Hemmelder MH; RECOVAC Consortium. Bouwmans P, et al. Among authors: gansevoort rt. Int J Infect Dis. 2024 May;142:106990. doi: 10.1016/j.ijid.2024.106990. Epub 2024 Feb 28. Int J Infect Dis. 2024. PMID: 38428480 Free article.
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial.
Bais T, Meijer E, Kramers BJ, Vart P, Vervloet M, Salih M, Bammens B, Demoulin N, Todorova P, Müller RU, Halbritter J, Paliege A, Gall EC, Knebelmann B, Torra R, Ong ACM, Karet Frankl FE, Gansevoort RT. Bais T, et al. Among authors: gansevoort rt. Trials. 2024 Feb 14;25(1):120. doi: 10.1186/s13063-024-07952-x. Trials. 2024. PMID: 38355627 Free PMC article.
An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD.
Taylor J, Thomas R, Metherall P, van Gastel M, Cornec-Le Gall E, Caroli A, Furlano M, Demoulin N, Devuyst O, Winterbottom J, Torra R, Perico N, Le Meur Y, Schoenherr S, Forer L, Gansevoort RT, Simms RJ, Ong ACM. Taylor J, et al. Among authors: gansevoort rt. Kidney Int Rep. 2023 Nov 4;9(2):249-256. doi: 10.1016/j.ekir.2023.10.029. eCollection 2024 Feb. Kidney Int Rep. 2023. PMID: 38344736 Free PMC article.
693 results